1 / 6

Hemato Oncology Testing Market Size, Share, Future Challenges, Revenue, Demand, Opportunity, Analysis and Industry, Fore

The rise in the prevalence of hematologic cancer, increment in knowledge of precision medicine and the increase in the amount of assays are likely to result in the rapid growth of the oncology research industry in the forecast years.

MargaretsHill
Download Presentation

Hemato Oncology Testing Market Size, Share, Future Challenges, Revenue, Demand, Opportunity, Analysis and Industry, Fore

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Adroit Market Research Hemato HematoOncology Testing Market Oncology Testing Market Size 2018, by Product (Service and Assay Kits), by Indication (Leukemia, Lymphoma, Other Cancers), Technology (NGS, PCR IHC, Cytogenetics, Others), End User (Hospitals, Laboratories, Academic & Research Institutes, Others), Region and Forecast 2019 to 2025 Single Use License: US$ 4400 Request Sample +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  2. Adroit Market Research Global Global Hemato HematoOncology Testing Market To Cross USD 4.39 Billion By 2025 Oncology Testing Market To Cross USD 4.39 Billion By 2025 The global hemato oncology testing market is anticipated to cross USD 4.39 billion by 2025, growing at a CAGR of over 13%. Increasing prevalence of blood cancer amongst children is anticipated to drive the demand for test kits in the coming years. Adroit Market Research report on global hemato oncology testing market gives a holistic view of the market from 2015 to 2025, which includes factors such as market drivers, restraints, opportunities, challenges and regulatory scenario. The market has been studied for historic years from 2015 to 2017, with the base year of estimation as 2018 and forecast from 2019 to 2025. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market competition with Porter's five forces analysis and positions the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global hemato oncology testing market have been studied in detail. According to the estimates of the Leukemia & Lymphoma Society, during 2019, over 82,000 cases of lymphoma will be diagnosed alone in the U.S., the country will also observe more than 8,000 and 74,000 cases of Hodgkin & Non-Hodgkin Lymphoma. With advancements in detection tests, the survival rate has escalated twice in past few years. High awareness rates coupled with NGO’s working to make people knowledgeable about symptoms, the consumption of testing kits is likely to rise in coming years. In terms of product, services accounted for noticeable market share in 2018 and is anticipated to maintain its position compared to assay kits. Additionally, in terms of technology NGS is anticipated to emerge as the fastest growing segment compared to others. +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  3. Adroit Market Research Global Global Hemato HematoOncology Testing Market To Cross USD 4.39 Billion By 2025 Oncology Testing Market To Cross USD 4.39 Billion By 2025 In terms of geography, Asia Pacific is likely to emerge as the most promising regional market by 2025. Easing of drug policies between India and china is likely to increase the trade of medical supplies within these countries this is anticipated to attract more companies to invest in the region. Such factors are likely to drive the Asia Pacific market in the coming years. Key vendors in the market include ARUP Laboratories Inc., Invivoscribe, Inc, Thermo Fisher Scientific, Inc, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Adaptive Biotechnologies, ArcherDx, Inc., MolecularMD , etc. Increasing spending on R&D by tier 1 companies has been a successful strategy for them in order to maintain their market position. For instance, Roche has been investing around 11%-13% of their revenues in R&D, also majority of the sales for the company has been from APAC. As a result of which, the company was successful in developing RealTime IDH1 and RealTime IDH2 PCR kits for rapid detection of the medical condition. Such strategies are anticipated to improve the rate of diagnosis and reduce the global economic burden of the disease in coming years. Browse the complete report on @ https://www.adroitmarketresearch.com/industry-reports/hemato-oncology- testing-market +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  4. Adroit Market Research Segment Overview of Global Segment Overview of Global hemato hematooncology oncology testing testingmarket market • Product Overview, 2015-2025 (USD Million) • Services • Assay Kits • Indication Overview, 2015-2025 (USD Million) • Leukemia • Acute Myeloid Leukemia • Acute Lymphocytic Leukemia • Others • Lymphoma • Non-Hodgkin Lymphoma • Hodgkin Lymphoma • Others • Technology Overview, 2015-2025 (USD Million) • Cytogenetics. • NGS • PCR • IHC • Others +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  5. Adroit Market Research Segment Overview of Global Segment Overview of Global hemato hematooncology oncology testing testingmarket market • End User Overview, 2015-2025 (USD Million) • Hospitals • Clinical Laboratories • Academic & Research Institutes • Others Regional Overview, 2015-2025 (USD Million) • North America • Europe • Asia Pacific • Latin America • Middle East & Africa Purchase a single user copy of the global hemato oncology testing market report@ https://www.adroitmarketresearch.com/researchreport/purchase/1512 +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  6. Adroit Market Research About Us About Us Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps. Our analysts have tracked high growth markets in chemicals & materials, healthcare & pharmaceuticals, semiconductor & electronics, energy & power, food & retail, consumer goods, technology, and machinery & equipment sectors across the world to identify new opportunities, potential customers, prepare go-to-market (GTM) strategies, identify segments for revenue growth for companies, and manymore. Contact Us US Headquarters Phone: +1 (214) 884-6068 Email: sales@adroitmarketresearch.com 3131 McKinney Ave Ste 600 Dallas, TX 75204 ,U.S.A +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

More Related